May. 08, 2014
NewsCompany News

SAFC and BioTools Collaborate to Provide End-to-End Chiral Technology Solutions

SAFC, Sigma-Aldrich's custom manufacturing and services business unit, has entered into a collaborative technology agreement with the company BioTools. The partnership aligns BioTools, a manufacturer of advanced chiroptical spectroscopic instruments, with the solid-state research and development business, Pharmorphix. The combined offer provides customers direct access to a comprehensive range of chiral structural determination tools and separation services in the market, potentially accelerating timelines to market for chiral-based drugs.

Pharmorphix solid state technologies contribute extensive expertise to the partnership in the application of powder and single-crystal X-ray diffraction technology, including chiral structure determination of small molecules and enantioselective resolution services using crystallization and chromatography. BioTools brings insight and proficiency in the field of vibrational optical activity (VOA) and the use of its advanced instruments and software.

"Our partnership with BioTools enables customers to approach a single service provider to get access to the highest levels of efficiency and confidence in structural determination, including the configuration of chiral structures," commented Dr. Chris Frampton, Chief Scientific Officer at SAFC's Pharmorphix Solid State Research Laboratories. "This extended range of structural and chiral separation solutions will play an important role in accelerating the drug discovery and development process."

"The alignment of knowledge, experienced staff, and advanced instrumentation and software creates a formidable force to effectively help researchers meet the complex challenges of chiral drug development," added BioTools President Dr. Rina Dukor.

BioTools

Pharmorphix

Contact

Impress Labs
605 E Grant Str., S. 106
Phoenix, AZ 85004, Arizona
USA
Phone: +1 503 9287828

Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.